Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CHF 135.3
Key Takeaways
Risk factor
Low price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Galderma Group AG is engaged in cosmetic industry. Its segment includes Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Data is available to registered users only
Target Price
The average target price of GALD.SW is 140 and suggests 4% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Data is available to registered users only
